Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 1;30(11):1742-1749.
doi: 10.5551/jat.64043. Epub 2023 Apr 21.

The Novel Biomarkers-Based HALP (Hemoglobin, Albumin, Lymphocyte and Platelet)-Prognostic Model for Acute and Subacute Patients with Cerebral Venous Sinus Thrombosis: A Retrospective Cohort Study

Shen Li  1   2   3 , Yuan Gao  1   2 , Kai Liu  1   2 , Jiawei Zhao  1   2   3 , Hui Fang  1   2 , Yongli Tao  1   2 , Lulu Pei  1   2 , Mengke Tian  1   2 , Hongbing Liu  1   2   3 , Xin Wang  1   2   3 , Zongping Xia  1   2   3 , Yuming Xu  1   2 , Bo Song  1   2
Affiliations

The Novel Biomarkers-Based HALP (Hemoglobin, Albumin, Lymphocyte and Platelet)-Prognostic Model for Acute and Subacute Patients with Cerebral Venous Sinus Thrombosis: A Retrospective Cohort Study

Shen Li et al. J Atheroscler Thromb. .

Abstract

Aim: Increasing evidences suggest that HALP is an independent predictor of prognosis in patients with inflammation. However, the relationship between HALP and prognosis in patients with cerebral venous sinus thrombosis (CVST) has not been studied. In this study, we aimed to evaluate the prognosis values of HALP in acute or subacute CVST and explore the new prognostic model for CVST.

Methods: Consecutive patients who were diagnosed as having acute and subacute CVST were retrospectively investigated. We determined the patients' functional outcomes by modified Rankin Scale (mRS). Multivariate logistic regression analysis was used to assess the relationship between factors and poor functional outcomes. The area under the ROC curve (AUC) was estimated to evaluate the ability of markers and models in predicting clinical prognosis. The prognostic model was presented as nomogram. In addition, the decision curve analysis (DCA) was used to analyze the benefit of this model. Furthermore, survival curves were described by the Kaplan-Meier analysis.

Results: A total of 270 patients were included of which 31 had poor outcome. Multivariable logistic regression analysis demonstrated HALP (OR=0.978, 95%CI: 0.958-0.999, P=0.039) was a protective predictor of outcome. The AUC of HALP was 0.749 (95% CI: 0.633-0.865, P=0.044). DCA demonstrated that this model significantly improved risk prediction at threshold probabilities of CVST at 0 to 85% compared to ISCVT-RS scores. Patients with higher HALP (P=0.006) presented higher overall survival rates.

Conclusion: HALP may be a potential protective marker in acute and subacute CVST patients. The new prognostic model with HALP had potentially better value for acute and subacute CVST patients.

Keywords: Acute and subacute cerebral venous sinus thrombosis; Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP); Prognostic model; Protective marker; Stroke.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest, financial or otherwise.

Figures

Fig.1.
Fig.1.
Heat map identifying potential prognostic values in CVST patients
Fig.2.
Fig.2.
ROC curve of HALP in CVST patients
Fig.3.
Fig.3.
Nomogram for the new values-based risk score in CVST patients
Fig.4.
Fig.4.
Decision curve analysis for the novel prediction model of CVST patients
Fig.5.
Fig.5.
Kaplan-Meier analysis for CVST patients with high/low HALP patients
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Sader N, de Lotbinière-Bassett M, Tso MK, Hamilton M. Management of Venous Sinus Thrombosis. Neurosurg Clin N Am, 2018; 29: 585-594 - PubMed
    1. Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke, 2012; 43: 3375-3377 - PubMed
    1. Akboga YE, Bektas H, Anlar O. Usefulness of platelet to lymphocyte and neutrophil to lymphocyte ratios in predicting the presence of cerebral venous sinus thrombosis and in-hospital major adverse cerebral events. J Neurol Sci, 2017; 380: 226-229 - PubMed
    1. Artoni A, Abbattista M, Bucciarelli P, Gianniello F, Scalambrino E, Pappalardo E, Peyvandi F, Martinelli I. Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Risk Factors for Venous Thrombosis. Clin Appl Thromb Hemost, 2018; 24: 808-814 - PMC - PubMed
    1. Meng R, Wang X, Hussain M, Dornbos D, 3rd, Meng L, Liu Y, Wu Y, Ning M, Ferdinando SB, Lo EH, Ding Y, Ji X. Evaluation of plasma D-dimer plus fibrinogen in predicting acute CVST. Int J Stroke, 2014; 9: 166-173 - PMC - PubMed